Compare HMY & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HMY | TXG |
|---|---|---|
| Founded | 1950 | 2012 |
| Country | South Africa | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 9.3B |
| IPO Year | 2002 | 2019 |
| Metric | HMY | TXG |
|---|---|---|
| Price | $14.38 | $69.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 18 |
| Target Price | $22.19 | ★ $77.50 |
| AVG Volume (30 Days) | 2.6M | ★ 3.7M |
| Earning Date | 02-04-2016 | 11-05-2026 |
| Dividend Yield | ★ 3.93% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $245,893,000.00 |
| Revenue This Year | $8.45 | N/A |
| Revenue Next Year | $13.94 | $10.11 |
| P/E Ratio | $15.60 | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $13.03 | $12.80 |
| 52 Week High | $26.04 | $102.81 |
| Indicator | HMY | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 26.93 | 43.85 |
| Support Level | $14.31 | $67.25 |
| Resistance Level | $16.33 | $102.81 |
| Average True Range (ATR) | 0.47 | 5.98 |
| MACD | -0.08 | -0.15 |
| Stochastic Oscillator | 3.25 | 9.65 |
Harmony Gold Mining Co Ltd is engaged in gold mining and related activities, including exploration, extraction, and processing. The group's primary product is gold bullion, produced at operations in South Africa and Papua New Guinea. Gold byproducts include uranium and silver. Strategic projects such as the Wafi-Golpu Project in the New Guinea Mobile Belt, the Eva Copper Project in the Mt Isa Inlier, Queensland, Australia, and the MAC Copper acquisition position the company as a gold-copper producer. The company operates across South Africa, Papua New Guinea, and Australia.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).